Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression.

Kim JM, Jeung HC, Rha SY, Yu EJ, Kim TS, Shin YK, Zhang X, Park KH, Park SW, Chung HC, Powis G.

Mol Cancer Ther. 2014 Dec;13(12):3074-85. doi: 10.1158/1535-7163.MCT-13-1001. Epub 2014 Oct 24.

PMID:
25344581
2.

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane.

Park JS, Jeung HC, Rha SY, Ahn JB, Kang B, Chon HJ, Hong MH, Lim S, Yang WI, Nam CM, Chung HC.

Cancer Chemother Pharmacol. 2014 Oct;74(4):799-808. doi: 10.1007/s00280-014-2551-4. Epub 2014 Aug 9.

PMID:
25107569
3.

Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer.

Koh MJ, Jeung HC, Namkoong K, Chung HC, Kang JI.

J Psychosom Res. 2014 Jul;77(1):76-80. doi: 10.1016/j.jpsychores.2014.04.008. Epub 2014 May 5.

PMID:
24913346
4.

Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer.

Zhang X, Zheng Z, Shin YK, Kim KY, Rha SY, Noh SH, Chung HC, Jeung HC.

Pathology. 2014 Jun;46(4):316-24. doi: 10.1097/PAT.0000000000000094.

PMID:
24798152
5.

Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.

Kim C, Chon H, Kang B, Kim K, Jeung HC, Chung H, Noh S, Rha S.

BMC Cancer. 2013 Aug 23;13:394. doi: 10.1186/1471-2407-13-394.

6.

Application of the adjuvant! Online model to Korean breast cancer patients: an assessment of prognostic accuracy and development of an alternative prognostic tool.

Jung M, Choi EH, Nam CM, Rha SY, Jeung HC, Lee SH, Yang WI, Roh JK, Chung HC.

Ann Surg Oncol. 2013 Aug;20(8):2615-24. doi: 10.1245/s10434-013-2956-z. Epub 2013 Mar 30.

PMID:
23543197
7.

Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells.

Chang H, Rha SY, Jeung HC, Park KH, Kim TS, Kim YB, Chung HC.

Int J Mol Med. 2013 May;31(5):1202-8. doi: 10.3892/ijmm.2013.1300. Epub 2013 Mar 13.

PMID:
23503666
8.

Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment.

Jung AR, Yoo JE, Shim YH, Choi YN, Jeung HC, Chung HC, Rha SY, Oh BK.

Anticancer Res. 2013 Mar;33(3):821-9.

PMID:
23482750
9.

Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice.

Roh MR, Zheng Z, Kim HS, Jeung HC, Rha SY, Chung KY.

Melanoma Res. 2013 Apr;23(2):114-24. doi: 10.1097/CMR.0b013e32835e7713.

PMID:
23358428
10.

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

Choi YH, Oh SC, Kim JS, Nam SH, Kim BS, Cho SH, Chung IJ, Song EK, Yim CY, Baek JH, Jeung HC, Hong YS, Yang SH, Kang HJ.

Cancer Chemother Pharmacol. 2012 Nov;70(5):665-72. doi: 10.1007/s00280-012-1956-1. Epub 2012 Aug 25.

PMID:
22926638
11.

Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer.

Kim YB, Jeung HC, Jeong I, Lee K, Rha SY, Chung HC, Kim GE.

J Radiat Res. 2013 Jan;54(1):52-60. doi: 10.1093/jrr/rrs074. Epub 2012 Aug 24.

12.

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.

Yeo W, Chung HC, Chan SL, Wang LZ, Lim R, Picus J, Boyer M, Mo FK, Koh J, Rha SY, Hui EP, Jeung HC, Roh JK, Yu SC, To KF, Tao Q, Ma BB, Chan AW, Tong JH, Erlichman C, Chan AT, Goh BC.

J Clin Oncol. 2012 Sep 20;30(27):3361-7. doi: 10.1200/JCO.2011.41.2395. Epub 2012 Aug 20.

13.

Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.

Kim HS, Kim SC, Kim SJ, Park CH, Jeung HC, Kim YB, Ahn JB, Chung HC, Rha SY.

BMC Genomics. 2012 Jul 30;13:348. doi: 10.1186/1471-2164-13-348.

14.

Body fluid MMP-2 as a putative biomarker in metastatic breast cancer.

Noh S, Jung JJ, Jung M, Kim KH, Lee HY, Wang B, Cho J, Kim TS, Jeung HC, Rha SY.

Oncol Lett. 2012 Mar;3(3):699-703. Epub 2012 Jan 3.

15.

FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective study.

Kang JI, Chung HC, Jeung HC, Kim SJ, An SK, Namkoong K.

Psychoneuroendocrinology. 2012 Sep;37(9):1569-76. doi: 10.1016/j.psyneuen.2012.02.017. Epub 2012 Mar 28.

PMID:
22459275
16.

Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma.

Roh MR, Zheng Z, Kim HS, Kwon JE, Jeung HC, Rha SY, Chung KY.

Exp Mol Pathol. 2012 Apr;92(2):236-42. doi: 10.1016/j.yexmp.2012.01.003. Epub 2012 Jan 26.

PMID:
22305927
17.

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

Kim GM, Jeung HC, Rha SY, Kim HS, Jung I, Nam BH, Lee KH, Chung HC.

Eur J Cancer. 2012 Mar;48(4):518-26. doi: 10.1016/j.ejca.2011.12.017. Epub 2012 Jan 12.

PMID:
22243774
18.

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

Lee J, Park SH, Chang HM, Kim JS, Choi HJ, Lee MA, Jang JS, Jeung HC, Kang JH, Lee HW, Shin DB, Kang HJ, Sun JM, Park JO, Park YS, Kang WK, Lim HY.

Lancet Oncol. 2012 Feb;13(2):181-8. doi: 10.1016/S1470-2045(11)70301-1. Epub 2011 Dec 20. Erratum in: Lancet Oncol. 2012 Feb;13(2):e49. Chang, Joung Soon [corrected to Jang, Joung Soon].

19.

Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.

Kim HS, Lee H, Jeung HC, Noh SH, Chung HC, Roh JK, Nam CM, Rha SY.

Jpn J Clin Oncol. 2011 Dec;41(12):1344-50. doi: 10.1093/jjco/hyr153.

20.

Methylation status of lamin A/C in gastric cancer cell lines.

Lee WS, Jung JJ, Jeung HC, Noh SW, Oh BK, Kim KY, Kim TS, Chung HC, Roh JK, Rha SY.

Hepatogastroenterology. 2012 Jun;59(116):1313-8. doi: 10.5754/hge11610.

PMID:
22057372
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk